Physician profile
David Jackson Shepherd
NPI 1790437614
$690.96
in general payments reported to CMS, 2019-2025
13 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $125 · 2023: $106 · 2024: $242 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $565.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $168.15 | 2023-2025 | Intellis Adaptivestim, Capstone Ptc Spinal System, Cd Horizon Spinal System |
| Abbvie INC. | $125.00 | 2022 | |
| Orthofix Medical, INC. | $68.44 | 2024 | Cervical-Stim |
| Spinefrontier, INC. | $63.36 | 2024 | Sijfuse, Inspan |
| Boston Scientific Corporation | $58.31 | 2025 | Intracept, Wavewriter Alpha Prime 16 |
| Ossur Americas, INC. | $39.24 | 2025 | |
| Djo, LLC | $35.43 | 2024 | Cmf |
| Gt Medical Technologies, INC | $28.05 | 2023-2024 | Gammatile, Gammatile |
| Smoky Mountain Surgical LLC | $27.81 | 2024 | |
| Molnlycke Health Care US, LLC | $22.96 | 2023 | Mepilex Border Ag, Mepitel Ag, Mepilex Border Post-Op |
| Cerapedics INC. | $18.78 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Astrazeneca Pharmaceuticals LP | $18.05 | 2023 | Andexxa |
| Globus Medical, INC. | $17.38 | 2024 | Fortify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Shepherd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.